Our QTc Workshop was a Huge Success!

Posted:
1
October 2004

The QTc workshop hosted by Richmond Pharmacology on 29th September was deemed a huge success. Representatives from top pharmaceutical companies gathered at St George's Hospital to enjoy first class seminars given by world leading experts in cardiology.Jörg Täubel, Managing Director of Richmond Pharmacology began the proceedings by welcoming guests and introducing the speakers for the day.Professor John Camm, Chairman of the Department of Cardiac and Vascular Sciences at St George's Hospital Medical School, the first to speak, defined the QT interval and its clinical relevance. He later provided an insight into the factors that influence the QT interval.Dr Elijah Behr from St George's Hospital Medical School gave a detailed presentation on the congenital syndromes of abnormal ventricular repolarisation. Dr Behr also reflected on the important role that pharmacogenomics will play in the development of drugs in the near future.Professor Marek Malik, also from St George's Hospital Medical School took to the rostrum after coffee to talk about the correction or control of the QT interval for heart rate. Later in the day, Professor Malik returned to give an entertaining presentation on how the QT interval should be measured and the possible implications of all these factors in Study Design.After a delicious buffet lunch, Dr Rashmi Shah from the MHRA, gave an insightful presentation on the regulatory aspects of drug induced QTinterval prolongation, and finished the workshop with a talk entitled The Definitive QT Study, which highlighted the importance of inclusion of such studies in adequate drug development programmes.Initial feedback from those that attended the workshop has been outstanding, everyone benefited from the highly educational and enjoyable day.Richmond Pharmacology continues to work closely with St George's Hospital Medical School to ensure we provide the expertise required for QTc studies. For more information on Richmond Pharmacology's QTc capabilities, please visit our services page.The event was filmed and will be available as a DVD pack in November.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more